Fapon · 13 hours ago
Senior/Principal Research Associate, LNP Discovery/PD
Fapon is an innovative biotechnology startup focused on advancing RNA therapeutics. The Senior/Principal Research Associate will lead LNP formulation process development for RNA delivery, optimizing formulations and collaborating with cross-functional teams to support drug development efforts.
BiotechnologyHealth CareManufacturingMedical
Responsibilities
Establish, execute and document protocols for preparation and characterization of targeted LNP formulations with nucleic acid cargo for in vitro and in vivo studies
Design and execute DOE-driven studies for LNP composition, mixing parameters and process optimization to improve formulation quality, stability, delivery efficiency and functional activity
Develop cell and molecular biology assays to assess the delivery efficiency of RNA cargo in mammalian primary cells to facilitate development of therapeutics drugs pipelines
Assist in the buildout of formulation and analytical capabilities with focus on delivery with nanoparticle technology, lyophilization and process development for scale up/production
Contribute to patent applications related to the delivery technology
Support technology transfer to CDMOs and Industry Partners
Foster collaborative relationships across the team and company and engage in a positive and exciting work environment
Contribute to hiring, training, and collaborating with scientists (as needed) to formulate, characterize, develop, and support assessment of efficacy
Plan and coordinate animal studies with in vivo team
Author technical documents, including SOPs for formulation processes and analytical methods, maintain diligent records and demonstrate proficiency in scientific communication
Support high-quality documentations to support regulatory filings
Qualification
Required
BS/MS in chemical engineering, chemistry, pharmaceutical sciences, or related field, preferably with industry experience of 2-5 years for MS or 5-8 years for BS candidates
Strong track record of productivity in nanoparticle research with an understanding of key challenges in nanoparticle/formulation scale-up and translation
Prior experience in developing lyophilization protocols for nanoparticle formulation, and stability testing is a plus
Technical proficiency with LNP formulation of RNA and analytical assays for particle characterization
Technical proficiency in developing cell and molecular biology assays to support drug product development
A minimum of 3-4 years of experience working with lipid nanoparticles for RNA delivery in any capacity
Preferred
Demonstrated capability in LNP formulation for nucleic acid delivery is must
LNP process development and scale-up experience is desired
Experience with tissue-specific targeted delivery of LNP-nucleic acid formulation is a plus
Demonstrated ability to present complex technical topics to a wide range of audiences with varying technical depth
Demonstrated proficiency in record keeping and documentations to support SOP generation, technology transfer and preferably regulatory filings
Benefits
Financial security through competitive compensation, incentives, and retirement plan
Health care and well-being programs including competitive medical, dental, vision & medical benefits
Generous paid time off including vacation, sick time, holidays, and winter shutdown
401(k) retirement savings with a generous company match
Commuter benefits
Other comprehensive voluntary benefits include but are not limited to pet insurance, life insurance, employee assistance program (EAP), discount programs, and many more
We continue to optimize our benefits & wellness programs as we grow our organization to make sure they meet our diverse workforce needs
The stability of a startup backed by a company with a record of strong financial performance year over year
Company
Fapon
FAPON is a biotechnology company that provides IVD reagent raw material manufacturing and a one-stop solution.
Funding
Current Stage
Public CompanyTotal Funding
$1.74M2019-01-01Post Ipo Equity
2017-05-16Post Ipo Equity· $1.74M
2016-08-18IPO
Recent News
Research and Markets
2025-11-04
Company data provided by crunchbase